APA (7th ed.) Citation

Chen, M., Chen, M., Kim, B., Kim, B., Robertson, N., Robertson, N., . . . Moore, A. (2023, June). Co-administration of temozolomide (TMZ) and the experimental therapeutic targeting miR-10b, profoundly affects the tumorigenic phenotype of human glioblastoma cells. Frontiers in Molecular Biosciences.

Chicago Style (17th ed.) Citation

Chen, Ming, et al. "Co-administration of Temozolomide (TMZ) and the Experimental Therapeutic Targeting MiR-10b, Profoundly Affects the Tumorigenic Phenotype of Human Glioblastoma Cells." Frontiers in Molecular Biosciences Jun. 2023.

MLA (9th ed.) Citation

Chen, Ming, et al. "Co-administration of Temozolomide (TMZ) and the Experimental Therapeutic Targeting MiR-10b, Profoundly Affects the Tumorigenic Phenotype of Human Glioblastoma Cells." Frontiers in Molecular Biosciences, Jun. 2023.